Black Rock Inc. Aura Biosciences, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Aura Biosciences, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 3,005,362 shares of AURA stock, worth $31 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,005,362

Previous 2,444,841 22.93%

Holding current value

$31 Million

Previous $19.2 Million 18.38%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$6.81 - $7.89 $3.82 Million - $4.42 Million	560,521 Added 22.93%	3,005,362 $22.7 Million
Q1 2024 May 10, 2024	BUY	$7.09 - $9.24 $2.45 Million - $3.2 Million	346,096 Added 16.49%	2,444,841 $19.2 Million
Q4 2023 Feb 13, 2024	BUY	$7.02 - $11.98 $1.65 Million - $2.81 Million	234,719 Added 12.59%	2,098,745 $18.6 Million
Q3 2023 Nov 13, 2023	SELL	$8.97 - $12.38 $72,710 - $100,352	-8,106 Reduced 0.43%	1,864,026 $16.7 Million
Q2 2023 Aug 11, 2023	BUY	$8.51 - $13.33 $4.6 Million - $7.21 Million	541,032 Added 40.65%	1,872,132 $23.1 Million
Q1 2023 May 12, 2023	BUY	$8.88 - $12.11 $2.47 Million - $3.37 Million	277,973 Added 26.4%	1,331,100 $12.4 Million
Q4 2022 Feb 13, 2023	BUY	$9.86 - $14.59 $391,165 - $578,814	39,672 Added 3.91%	1,053,127 $11.1 Million
Q3 2022 Nov 14, 2022	BUY	$13.1 - $20.34 $1.66 Million - $2.58 Million	126,732 Added 14.29%	1,013,455 $18.4 Million
Q2 2022 Aug 12, 2022	BUY	$12.37 - $21.86 $7.57 Million - $13.4 Million	611,696 Added 222.41%	886,723 $12.6 Million
Q1 2022 May 12, 2022	BUY	$15.94 - $23.34 $577,729 - $845,934	36,244 Added 15.18%	275,027 $6.05 Million
Q4 2021 Feb 10, 2022	BUY	$14.76 - $24.89 $3.52 Million - $5.94 Million	238,783 New	238,783 $4.06 Million

Others Institutions Holding AURA

# of Institutions

Shares Held

37.6M

Call Options Held

122K

Put Options Held

38.5K

View Full List

About Aura Biosciences, Inc.

Ticker AURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,273,600
Market Cap $302M
Description
Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...

More about AURA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account